tirzepatide and mcas Can GLP-1 Medications Help MCAS, Fatigue, More? Tirzepatide reduces food intake and

L -Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis A Randomized and Controlled Clinical Trial

Track hunger timing and types of cravings to see if they are physical hunger or habit-driven

The balance favors building over breaking down

Psychosom Med 63(4):619630

The combination of medication-induced appetite loss plus deliberate fasting creates a dangerous metabolic state that can lead to muscle loss, bone density decline, and nutrient deficiencies within weeks

primarily to help manage blood sugars to control, decrease appetite, and also that impacts our digestion as well," she said